Loading...
New antiviral therapies for chronic hepatitis C
Chronic hepatitis C is an important health issue worldwide. The current standard therapy is based on a combination of pegylated-interferon (pegIFN) and ribavirin (RBV), but this treatment leads to only ~50% sustained virological response (SVR) in patients with HCV genotype 1 and high viral loads, wh...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer-Verlag
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2940000/ https://ncbi.nlm.nih.gov/pubmed/21063477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-010-9193-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|